A secondary analysis of study on naldemedine’s effectiveness for preventing OIC found the agent also prevents another common side effect of opioids.

Phase 2 TBCRC049 trial results show tucatinib triplet therapy improves survival in HER2+ breast cancer patients with ...

HRD-positive tumors derived the largest median PFS gain with rucaparib maintenance versus placebo, consistent with PARP ...

Customers who have purchased any of the affected items are advised to take note of the possible health risks and follow the official guidance ...

Recent Phase 2 topline results demonstrate NS002’s potential for best-in-class epinephrine delivery, with statistically ...

Glucocorticoid exposure was linked to higher incident toxicity rates, including ≥1 toxicity (61.9% vs 52.3%) and ≥3 ...

We asked four gastroenterologists which symptoms you should never ignore—and what they might signal.

Big food companies are starting to market to people on the powerful new obesity meds with labels that say "GLP-1 Friendly." ...

Fur seal die-offs in the Pribilof Islands, attributed to algal toxins, are part of a trend affecting people who depend on the ...

Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...